XML 56 R46.htm IDEA: XBRL DOCUMENT v3.7.0.1
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
May 26, 2016
Mar. 16, 2016
Oct. 07, 2013
Mar. 24, 2010
Dec. 31, 2016
Sep. 30, 2016
Jan. 31, 2016
May 31, 2015
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
May 31, 2016
May 31, 2014
Related-Party Transactions (Textual) [Abstract]                          
Long-term other assets         $ 2,113,147       $ 1,525,154   $ 2,113,147    
Subsidiary ownership percentage by parent                         85.00%
Receivable from sale of intangible assets                       $ 2,000,000  
Future payments to be received from sale of intangible assets               $ 1,000,000          
Ownership of investment               16.80%          
Distributed                     1,000,000    
Carrying value of investment                         $ 0
Investment in affiliated entity - PLS         3,777,510       $ 3,027,549   3,777,510    
Available-for-sale Securities [Member]                          
Related-Party Transactions (Textual) [Abstract]                          
Investment owned (shares)                 395,758     395,758  
Available-for-sale Securities [Member] | VGX International [Member]                          
Related-Party Transactions (Textual) [Abstract]                          
Investment owned (shares)               465,364          
GeneOne Life Sciences [Member]                          
Related-Party Transactions (Textual) [Abstract]                          
Milestone-based ownership target 35.00%           35.00%            
Term     20 years                    
Payment received for license granted       $ 3,000,000                  
Deferred revenue from affiliated entity       $ 3,000,000                  
Period over which deferred revenue from affiliated entity will be recognized in years       8 years                  
Revenue from related parties                 $ 167,000 $ 113,000      
Operating expenses related to affiliated entity                 428,000 212,000      
Accounts receivable balance         441,000       495,000   441,000    
Accounts payable and accrued liability         379,000       41,000   379,000    
Long-term other assets         571,000       $ 494,000   571,000    
OncoSec [Member] | First warrant [Member]                          
Related-Party Transactions (Textual) [Abstract]                          
Common stock purchase warrant (in shares)           50,000              
Exercise price of a five-year warrant ($ per share)           $ 24.00              
OncoSec [Member] | Second warrant [Member]                          
Related-Party Transactions (Textual) [Abstract]                          
Common stock purchase warrant (in shares)                 150,000        
Exercise price of a five-year warrant ($ per share)                 $ 20.00        
Director [Member]                          
Related-Party Transactions (Textual) [Abstract]                          
Term   5 years                      
Revenue from related parties                 $ 614,000 0      
Operating expenses related to affiliated entity                 543,000 $ 0      
Expenses to reimburse   $ 3,100,000                      
Award         6,100,000                
Accounts receivable         152,000       516,000   152,000    
Accounts payable/accrued liabilities         $ 671,000       $ 483,000   671,000    
Noncontrolling Interest [Member]                          
Related-Party Transactions (Textual) [Abstract]                          
Distributed                     $ 150,000